5580105 Future Strengths Trigger Date
5580105 Future Strengths Trigger Date. Means, with respect to the 55/80/105 Future Generic Products only and for which Aurobindo has an approved ANDA, on a 55/80/105 Future Generic Product-by-55/80/105 Future Generic Product basis, the earliest of: (a) February ***, 2019; (b) ***; or (c) ***. ***. ***.
All Definitions
Found in
MEDICIS PHARMACEUTICAL CORP contract